Krka d. d (KRK) - Net Assets

Latest as of September 2025: zł2.31 Billion PLN ≈ $634.38 Million USD

Based on the latest financial reports, Krka d. d (KRK) has net assets worth zł2.31 Billion PLN (≈ $634.38 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł2.97 Billion ≈ $816.73 Million USD) and total liabilities (zł662.58 Million ≈ $182.35 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Krka d. d (KRK) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets zł2.31 Billion
% of Total Assets 77.67%
Annual Growth Rate 5.53%
5-Year Change 27.74%
10-Year Change 59.16%
Growth Volatility 3.15

Krka d. d - Net Assets Trend (2010–2024)

This chart illustrates how Krka d. d's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Krka d. d for the complete picture of this company's asset base.

Annual Net Assets for Krka d. d (2010–2024)

The table below shows the annual net assets of Krka d. d from 2010 to 2024. For live valuation and market cap data, see Krka d. d market cap and net worth.

Year Net Assets Change
2024-12-31 zł2.24 Billion
≈ $615.87 Million
+2.57%
2023-12-31 zł2.18 Billion
≈ $600.45 Million
+2.02%
2022-12-31 zł2.14 Billion
≈ $588.55 Million
+11.43%
2021-12-31 zł1.92 Billion
≈ $528.16 Million
+9.55%
2020-12-31 zł1.75 Billion
≈ $482.12 Million
+5.06%
2019-12-31 zł1.67 Billion
≈ $458.92 Million
+8.26%
2018-12-31 zł1.54 Billion
≈ $423.90 Million
+3.53%
2017-12-31 zł1.49 Billion
≈ $409.44 Million
+2.99%
2016-12-31 zł1.44 Billion
≈ $397.53 Million
+2.74%
2015-12-31 zł1.41 Billion
≈ $386.95 Million
+4.00%
2014-12-31 zł1.35 Billion
≈ $372.06 Million
+1.45%
2013-12-31 zł1.33 Billion
≈ $366.75 Million
+7.42%
2012-12-31 zł1.24 Billion
≈ $341.41 Million
+8.84%
2011-12-31 zł1.14 Billion
≈ $313.68 Million
+8.21%
2010-12-31 zł1.05 Billion
≈ $289.89 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Krka d. d's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 161.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings zł2.24 Billion 100.79%
Common Stock zł54.73 Million 2.47%
Other Comprehensive Income zł-14.57 Million -0.66%
Total Equity zł2.22 Billion 100.00%

Krka d. d Competitors by Market Cap

The table below lists competitors of Krka d. d ranked by their market capitalization.

Company Market Cap
Zhejiang Jingsheng Mech Electric
SHE:300316
$8.81 Billion
Campbell’s Co
NYSE:CPB
$8.81 Billion
BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSG
$8.82 Billion
Sartorius Aktiengesellschaft
XETRA:SRT3
$8.83 Billion
Oracle Financial Services Software Limited
NSE:OFSS
$8.80 Billion
Baiyin Nonferrous Group Co Ltd
SHG:601212
$8.79 Billion
Zions Bancorporation
NASDAQ:ZION
$8.79 Billion
AZUL SA PFD ADR 1
F:8AZA
$8.79 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Krka d. d's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,162,055,000 to 2,218,183,000, a change of 56,128,000 (2.6%).
  • Net income of 356,986,000 contributed positively to equity growth.
  • Dividend payments of 230,884,000 reduced retained earnings.
  • Share repurchases of 25,002,000 reduced equity.
  • Other comprehensive income decreased equity by 18,180,000.
  • Other factors decreased equity by 26,792,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income zł356.99 Million +16.09%
Dividends Paid zł230.88 Million -10.41%
Share Repurchases zł25.00 Million -1.13%
Other Comprehensive Income zł-18.18 Million -0.82%
Other Changes zł-26.79 Million -1.21%
Total Change zł- 2.60%

Book Value vs Market Value Analysis

This analysis compares Krka d. d's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 14.54x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 33.68x to 14.54x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2010-12-31 zł31.12 zł1048.00 x
2011-12-31 zł33.89 zł1048.00 x
2012-12-31 zł37.23 zł1048.00 x
2013-12-31 zł40.34 zł1048.00 x
2014-12-31 zł41.22 zł1048.00 x
2015-12-31 zł43.16 zł1048.00 x
2016-12-31 zł44.54 zł1048.00 x
2017-12-31 zł46.15 zł1048.00 x
2018-12-31 zł48.04 zł1048.00 x
2019-12-31 zł52.41 zł1048.00 x
2020-12-31 zł55.52 zł1048.00 x
2021-12-31 zł61.09 zł1048.00 x
2022-12-31 zł68.19 zł1048.00 x
2023-12-31 zł69.85 zł1048.00 x
2024-12-31 zł72.06 zł1048.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Krka d. d utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 16.09%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 18.69%
  • • Asset Turnover: 0.67x
  • • Equity Multiplier: 1.28x
  • Recent ROE (16.09%) is above the historical average (13.64%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2010 16.26% 16.93% 0.68x 1.41x zł65.85 Million
2011 14.30% 15.14% 0.70x 1.35x zł48.98 Million
2012 12.91% 13.99% 0.70x 1.31x zł36.01 Million
2013 12.98% 14.39% 0.68x 1.32x zł39.71 Million
2014 12.31% 13.95% 0.66x 1.33x zł31.16 Million
2015 11.27% 13.59% 0.64x 1.29x zł17.77 Million
2016 7.51% 9.23% 0.61x 1.32x zł-35.89 Million
2017 10.26% 12.05% 0.66x 1.29x zł3.93 Million
2018 11.35% 13.11% 0.67x 1.29x zł20.83 Million
2019 14.75% 16.44% 0.68x 1.31x zł79.11 Million
2020 16.69% 18.96% 0.69x 1.28x zł116.66 Million
2021 16.23% 19.75% 0.62x 1.33x zł118.69 Million
2022 17.15% 21.15% 0.64x 1.27x zł151.43 Million
2023 14.52% 17.38% 0.65x 1.28x zł97.74 Million
2024 16.09% 18.69% 0.67x 1.28x zł135.17 Million

Industry Comparison

This section compares Krka d. d's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $439,847,293
  • Average return on equity (ROE) among peers: 5.82%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Krka d. d (KRK) zł2.31 Billion 16.26% 0.29x $8.81 Billion
Celon Pharma SA (CLN) $439.85 Million 5.82% 0.19x $315.71 Million

About Krka d. d

WAR:KRK Poland Drug Manufacturers - Specialty & Generic
Market Cap
$8.81 Billion
zł32.01 Billion PLN
Market Cap Rank
#2478 Global
#10 in Poland
Share Price
zł1048.00
Change (1 day)
-0.19%
52-Week Range
zł758.00 - zł1060.00
All Time High
zł1060.00
About

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company's prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolis… Read more